Covid-19: India slows vital vaccine exports as cases soar
As a major supplier, the development is a blow to vital vaccination programmes in poorer countries.
India, the “pharmacy of the world”, has put the brakes on exporting Covid-19 vaccines as it battles a new wave of infections at home and a faltering inoculation drive.
As a major supplier, the development is a blow to vital vaccination programmes in poorer countries under the Covax global inoculation initiative led by the World Health Organization and the Gavi alliance.
So far, India has sent more than 60 million doses to 76 countries, mostly AstraZeneca shots manufactured by the Serum Institute of India (SII), the world’s largest vaccine maker by volume.
On Thursday, Gavi said vaccine deliveries planned for the rest of March and April “will face delays” because of “increased demand of Covid-19 vaccines in India”.
An Indian government source said late on Thursday it had “not imposed any ban on exports of vaccines unlike many other countries. We remain committed to helping the world with vaccines, including through Covax.”
Prime Minister Narendra Modi urged officials to ensure seamless and... READ MORE
India's crisis highlights the need to increase investment in the... READ MORE
Measures taken by government successful in controlling spread of the ... READ MORE
Previous studies had shown it was linked to a higher likelihood of... READ MORE
The report must also include a QR code which is linked to the... READ MORE
The space agency had originally planned the flight for April 11 but... READ MORE
Top health official suggests face shields for kids aged below 3 READ MORE
The man was fined for not following safety protocols. READ MORE